Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe
NCT02597439
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
145
Enrollment
OTHER
Sponsor class
Conditions
Ultra High Risk for Psychosis
Interventions
DRUG:
Omega-3 fatty acids
OTHER:
Placebo
Sponsor
Rene Kahn